BusinessStreetwise Reports Publishes Portfolio Manager’s Biotech Watchlist Picks for 2018By Nasdaq OMXJan 8, 2018, 1:45 PM UTC
BusinessStreetwise Reports Examines Analyst’s View of ‘One of the Most Undervalued Biotech Companies in Canada’By Nasdaq OMXDec 7, 2017, 1:45 PM UTC
BusinessStreetwise Reports Examines How One Analyst Says This Biotech Company Could Potentially 'Double'By Nasdaq OMXNov 15, 2017, 2:00 PM UTC
